Real-world treatment and outcomes of ALK-positive metastatic non-small cell lung cancer in a Southeast Asian country

• Main Authors: Poh, Mau Ern, How, Soon Hin, Ho, Gwo Fuang, Pang, Yong Kek, Hasbullah, Harissa H., Tho, Lye Mun, Nor, Ibtisam Muhamad, Lim, Bee Chiu, Ho, Kean Fatt, Thiagarajan, Muthukkumaran, Samsudin, Azlina, Omar, Azza, Ong, Choo Khoon, Soon, Sing Yang, Tan, Justin Yu Kuan, Abidin, Muhammad Adil Zainal
• Format: Article
• Published: Dove Medical Press LTD 2023
• Subjects: RC0254 Neoplasms. Tumors. Oncology (including Cancer)
• Online Access: http://eprints.um.edu.my/39088/

Purpose: Anaplastic lymphoma kinase (ALK) inhibitors are associated with good overall survival (OS) for ALK-positive metastatic non-small cell lung cancer (NSCLC). However, these treatments can be unavailable or limited by financial constraints in developing countries. Using data from a nationwide l...